NCT04031261View on ClinicalTrials.gov

National Validation and Sensitivity to Change of the SAQ

CompletedOBSERVATIONAL
Enrollment

410

Participants

Timeline

Start Date

April 10, 2019

Primary Completion Date

March 23, 2020

Study Completion Date

March 23, 2020

Conditions
AsthmaSevere Asthma
Trial Locations (5)

B9 5SS

Birmingham Heartlands Hospital, Birmingham

EX2 5DW

Royal Devon & Exeter Hospital, Exeter

SW3 6NP

Royal Brompton Hospital, London

M23 9LT

Wythenshawe Hospital - Manchester, Manchester

Pl4 8DH

University Hopsitals Plymouth NHS Trust, Plymouth

All Listed Sponsors
collaborator

University of Plymouth

OTHER

lead

University Hospital Plymouth NHS Trust

OTHER

NCT04031261 - National Validation and Sensitivity to Change of the SAQ | Biotech Hunter | Biotech Hunter